← Back to Patent Explorer
US5503869A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for forming medicament carrier for dry powder inhalator

Assignee: SmithKline Beecham Corp
•
Filing: 1994-10-21
•
Granted: 1996-04-02
•
Expires: 2014-10-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for forming a medicament carrier for use in a dry powder inhalator device wherein the medicament carrier has at least one carrier screen portion. The carrier screen portion defines a plurality of interstices therein and carries a powdered medicament, applied in a suspension and the suspending agent then evaporated off, which is substantially loaded onto the screen portion surface such that the interstices of the carrier screen portion are at least partially open and free of the dry powdered medicament.

Inventors

  • 👤 Michiel M. Van Oort

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 08:02
CPC Classifications
A; A61; A61M; A61M15/00; A61M15/0028; A61M15/0045; A61M15/0046; A61M15/0048; A61M15/005; A61M15/0051; A61M2202/00; A61M2202/06; A61M2202/064

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 106 words
A process for forming a medicament carrier to use in a dry powder inhalator device comprising the steps of: (a) providing a carrier having a plurality of carrier surfaces defining a plurality of interstices therebetween; (b) applying a suspension comprising a suspending agent and at least one dose of a powdered medicament to the carrier surfaces of the carrier so that the interstices are at least partially open and free of the suspension; and (c) evaporating off the suspending agent from the carrier surfaces so as to leave the powdered medicament deposited primarily upon the carrier surfaces of the carrier and not within the interstices thereof.
Claim 2
Dependent Claim 106 words
A process for forming a medicament carrier to use in a dry powder inhalator device comprising the steps of: (a) providing a carrier having a plurality of carrier surfaces defining a plurality of interstices therebetween; (b) applying a suspension comprising a suspending agent and at least one dose of a powdered medicament to the carrier surfaces of the carrier so that the interstices are at least partially open and free of the suspension; and (c) evaporating off the suspending agent from the carrier surfaces so as to leave the powdered medicament deposited primarily upon the carrier surfaces of the carrier and not within the interstices thereof.
Claim 3
Dependent Claim 15 words
The process according to claim 1 wherein said carrier surfaces comprise a carrier screen portion.
Claim 4
Dependent Claim 17 words
The process according to claim 1 wherein said carrier surfaces comprise a plurality of spherical substrate elements.
Claim 5
Dependent Claim 30 words
The process according to claim 1 wherein said medicament is selected from the group consisting of albuterol, terbutaline, isoproterenol, metaprotaranol, pirbuterol, salmeterol hydroxynapthoate, fluticasone propionate, budesonide, beclomethasone dipropionate, and triacetonide.
Claim 6
Dependent Claim 23 words
The process according to claim 1 wherein the suspending agent is selected from the group consisting of fluorinated hydrocarbons, hydrocarbons, and mixtures thereof.
Claim 7
Dependent Claim 24 words
The process according to claim 5 wherein the fluorinated hydrocarbon suspending agent is selected from the group consisting of perfluoropentane, perfluorohexane, perfluoromethylcyclohexane, and perfluorocyclohexane.
Claim 8
Dependent Claim 114 words
A process for forming a medicament carrier to use in a dry powder inhalator device comprising the steps of: (a) providing a carrier having at least one carrier screen portion including a plurality of carrier surfaces defining a plurality of interstices therebetween; (b) applying a suspension comprising a suspending agent and at least one dose of a powdered medicament to the surfaces of the carrier screen portion so that the interstices are at least partially open and free of the suspension; and (c) evaporating off the suspending agent from the carrier screen portion so as to leave the powdered medicament deposited primarily upon the surfaces of the carrier and not within the interstices thereof.
Claim 9
Dependent Claim 114 words
A process for forming a medicament carrier to use in a dry powder inhalator device comprising the steps of: (a) providing a carrier having at least one carrier screen portion including a plurality of carrier surfaces defining a plurality of interstices therebetween; (b) applying a suspension comprising a suspending agent and at least one dose of a powdered medicament to the surfaces of the carrier screen portion so that the interstices are at least partially open and free of the suspension; and (c) evaporating off the suspending agent from the carrier screen portion so as to leave the powdered medicament deposited primarily upon the surfaces of the carrier and not within the interstices thereof.
Claim 10
Dependent Claim 30 words
The process according to claim 7 wherein said medicament is selected from the group consisting of albuterol, terbutaline, isoproterenol, metaprotaranol, pirbuterol, salmeterol hydroxynapthoate, fluticasone propionate, budesonide, beclomethasone dipropionate, and triacetonide.
Claim 11
Dependent Claim 23 words
The process according to claim 7 wherein the suspending agent is selected from the group consisting of fluorinated hydrocarbons, hydrocarbons, and mixtures thereof.
Claim 12
Dependent Claim 24 words
The process according to claim 9 wherein the fluorinated hydrocarbon suspending agent is selected from the group consisting of perfluoropentane, perfluorohexane, perfluoromethylcyclohexane, and perfluorocyclohexane.

References Cited (Backward Citations)

US3992144A Cited
US4841964A Cited
US4601897A Cited
US5348730A Cited
DE4020571A1 Cited
WO1992000115A1 Cited
US5173298A Cited
US5369117A Cited
WO1994020164A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-02 1999-10-02 2000-04-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-02 2003-10-02 2004-04-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-02 2007-10-02 2008-04-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag